SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel

Evaluation of SARS‐CoV‐2 antibody levels on hospital admission as a correlate of protection against mortality

(2023) Sylvia Mink et al.   JOURNAL OF INTERNAL MEDICINE

Third dose of SARS‐CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients

(2023) Marzia Montalbano et al.   LIVER INTERNATIONAL

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

(2022) Emma K. Accorsi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines

(2022) Yusha Araf et al.   JOURNAL OF MEDICAL VIROLOGY

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

(2022) Delphine Planas et al.   NATURE

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

(2022) Henning Gruell et al.   NATURE MEDICINE

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

(2022) Peter B. Gilbert et al.   SCIENCE

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

(2022) John P. Evans et al.   Science Translational Medicine

Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review

(2022) Chen Chen et al.   JOURNAL OF INFECTIOUS DISEASES

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

(2022) Hannah G Rosenblum et al.   LANCET INFECTIOUS DISEASES

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

(2022) Nick Andrews et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia

(2022) Su Lan Yang et al.   Emerging Microbes & Infections

Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update

(2022) Paolo Pelosi et al.   Journal of Clinical Medicine

Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines

(2022) Alessandro Sette et al.   IMMUNOLOGICAL REVIEWS

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections

(2022) Birte Möhlendick et al.   Frontiers in Immunology

Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature

(2022) Serena Vita et al.   Pathogens

Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era

(2022) George N. Ioannou et al.   ANNALS OF INTERNAL MEDICINE

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

(2022) Adarsh Bhimraj et al.   CLINICAL INFECTIOUS DISEASES

Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study

(2022) Chiara Farroni et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Covid-19 Vaccines — Immunity, Variants, Boosters

(2022) Dan H. Barouch   NEW ENGLAND JOURNAL OF MEDICINE

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV

(2022) Alessandra Vergori et al.   Nature Communications

Longitudinal Serological Surveillance for COVID-19 Antibodies after Infection and Vaccination

(2022) Christopher McGee et al.   Microbiology Spectrum

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes

(2022) Sarah A. Buchan et al.   JAMA Network Open

Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

(2022) Alessandra Aiello et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus

(2021) Giulia Matusali et al.   Viruses-Basel

Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

(2021) Silvia Meschi et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

(2021) Moriah Bergwerk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination

(2021) Vincenzo Puro et al.   Vaccines

Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine

(2021) Chiara Agrati et al.   Microorganisms

A clinical case definition of post-COVID-19 condition by a Delphi consensus

(2021) Joan B Soriano et al.   LANCET INFECTIOUS DISEASES

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

(2021) Luisa F. Duarte et al.   Frontiers in Immunology

Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine

(2021) Davide Ferrari et al.   Vaccines

COVID-19 and Post-Acute COVID-19 Syndrome: From Pathophysiology to Novel Translational Applications

(2021) Pasquale Ambrosino et al.   Biomedicines